Angiogenesis 2024: AVD-104 for Geographic Atrophy

Carl Danzig, MD, sat down with Martin David Harp of Ophthalmology Times to discuss his presentation AVD-104 for Geographic Atrophy: Glyco-immunologic modulation of macrophage activity from the Angiogenesis Exudation and Degeneration 2024 event.

Recent Videos

Related Content

Advertisement

---

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Article

---

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches

Podcast

---

Richard Rosen, MD, honored with distinguished award from ASRS

Article

---

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast

---

ASRS 2024: TEASE-3 study data shows progression stalled in early-stage Stargardt disease patients treated with gildeuretinol

Article

---

ASRS 2024: Retina surgeon dexterity affected by external exposures

Article

Related Content

Advertisement

---

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Article

---

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches

Podcast

---

Richard Rosen, MD, honored with distinguished award from ASRS

Article

---

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast

---

ASRS 2024: TEASE-3 study data shows progression stalled in early-stage Stargardt disease patients treated with gildeuretinol

Article

---

ASRS 2024: Retina surgeon dexterity affected by external exposures

Article